Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nanobiotix S.A. ADR
(NQ:
NBTX
)
4.770
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nanobiotix S.A. ADR
< Previous
1
2
3
4
5
6
7
8
9
Next >
Nanobiotix Provides Business Update and Reports Financial Results for the First Half of 2022
September 28, 2022
From
Nanobiotix
Via
Business Wire
Earnings Scheduled For September 28, 2022
September 28, 2022
Companies Reporting Before The Bell • Lilium (NASDAQ:LILM) is expected to report earnings for its second quarter.
Via
Benzinga
Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022
September 22, 2022
From
Nanobiotix
Via
Business Wire
Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial
September 22, 2022
Nanobiotix (NASDAQ: NBTX) determined the recommended phase 2 dose (RP2D) of the NBTXR3 combo regime for inoperable locoregional recurrent or recurrent and metastatic head and neck squamous cell...
Via
Benzinga
Nanobiotix Establishes Recommended Dose for Planned Registrational Study Evaluating NBTXR3 Plus Anti-PD-1 for Patients With Metastatic Head and Neck Cancer Resistant to Prior Immunotherapy
September 21, 2022
From
Nanobiotix
Via
Business Wire
Nanobiotix Announces Agreement in Principle to Restructure Existing Loan Agreement With European Investment Bank, Extending Operating Runway Into Q1 2024
September 12, 2022
From
Nanobiotix
Via
Business Wire
Nanobiotix: Voting Rights and Shares Capital of the Company
September 08, 2022
From
Nanobiotix
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 08, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
September 08, 2022
Good morning! It's time for another overview of the biggest pre-market stock movers as we see what's happening on Thursday!
Via
InvestorPlace
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
September 07, 2022
Via
Benzinga
NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluating NBTXR3 for the Treatment of Head and Neck Cancer
September 07, 2022
From
NANOBIOTIX
Via
Business Wire
NANOBIOTIX Co-Founder and CEO Laurent Levy Named to 2022 PharmaVoice 100 List of Most Inspiring People in Life Sciences
September 06, 2022
From
NANOBIOTIX
Via
Business Wire
Nanobiotix to Present During the H.C. Wainwright Global Investment Conference in September 2022
August 31, 2022
From
NANOBIOTIX
Via
Business Wire
NANOBIOTIX: Voting Rights and Shares Capital of the Company
August 09, 2022
From
Nanobiotix
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
August 01, 2022
Via
Benzinga
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
August 02, 2022
Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.
Via
Benzinga
This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session
August 01, 2022
Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
July 29, 2022
Gainers Nanobiotix (NASDAQ:NBTX) shares rose 16.4% to $2.7 during Friday's after-market session. The company's market cap stands at $94.1 million.
Via
Benzinga
Half-year Report on the Nanobiotix Liquidity Contract With Gilbert Dupont
July 13, 2022
From
Nanobiotix
Via
Business Wire
NANOBIOTIX: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
June 09, 2022
From
Nanobiotix
Via
Business Wire
NANOBIOTIX: New Data Featuring NBTXR3 Plus Chemoradiation and in the Preoperative Setting Support Broad Applicability for Head and Neck Cancer and Other Solid Tumor Indications
June 05, 2022
From
NANOBIOTIX
Via
Business Wire
NANOBIOTIX Annual Shareholders’ General Meeting to Be Held on June 23, 2022
June 02, 2022
From
Nanobiotix
Via
Business Wire
CORRECTING and REPLACING: NANOBIOTIX Provides First Quarter Operational and Financial Update
May 18, 2022
From
Nanobiotix
Via
Business Wire
NANOBIOTIX Provides First Quarter Operational and Financial Update
May 18, 2022
From
Nanobiotix
Via
Business Wire
NANOBIOTIX to Present During the Jefferies Healthcare Conference in June 2022
May 17, 2022
From
Nanobiotix
Via
Business Wire
NANOBIOTIX to Participate in Two Upcoming Investor Conferences
May 11, 2022
From
Nanobiotix
Via
Business Wire
7 Biotech Stocks With Key Catalysts for May
May 11, 2022
The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns.
Via
InvestorPlace
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
May 10, 2022
From
Nanobiotix
Via
Business Wire
NANOBIOTIX to Announce First Quarter 2022 Financial Results on May 18, 2022
May 04, 2022
From
NANOBIOTIX
Via
Business Wire
New Data Featuring NANOBIOTIX Lead Product Candidate NBTXR3 to Be Presented at the 2022 ASCO Annual Meeting
May 02, 2022
From
NANOBIOTIX
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.